Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 8-K Event Other events
  2. 424B3 Offering Prospectus
  3. 424B3 Offering Prospectus
  4. EFFECT Other Notice of Effectiveness
  5. 8-K Event Other events
  6. S-3/A Offering Registration Statement
  7. SC 13D/A Stake Beneficial Ownership Report
  8. 4 Open-market buy EVP and Chief Content Officer bought 5,000 shares at $0.37 ($1,850)
  9. 8-K Event Material agreement
  10. S-3 Offering Registration Statement
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. 8-K Event Material agreement
  14. 4 Open-market buy EVP and Chief Content Officer bought 10,000 shares at $0.43 ($4,280)
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. SC 13D/A Stake Beneficial Ownership Report
  18. 8-K Event Shareholder vote results
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 48 of 77 · 1,525 filings